MedPath

The Public Private Partnership Addressing Literacy-Numeracy to Improve Diabetes Care

Not Applicable
Completed
Conditions
Type 2 Diabetes
Interventions
Other: Standard Diabetes Education
Other: Enhanced Diabetes Education
Registration Number
NCT01344668
Lead Sponsor
Vanderbilt University
Brief Summary

The primary hypotheses are that the intervention will improve A1C, blood pressure, lipids, weight, self-efficacy, self-management behaviors, and use of clinical services at 12 and 24 months follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
411
Inclusion Criteria
  • Patient has a clinical diagnosis of Type 2 Diabetes
  • Age 18-85 years
  • English or Spanish speaking
  • Most recent A1C ≥ 7.5%
  • Patient agrees to participate in the study for the full two years duration.
Exclusion Criteria
  • Poor visual acuity (vision worse than 20/50 using Rosenbaum Pocket Screener) -- Significant dementia or psychosis (by health provider report or chart review)
  • Terminal illness with anticipated life expectancy < 2 years (per health provider or patient report).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Diabetes EducationStandard Diabetes EducationStandard Diabetes Education
Enhanced Diabetes EducationEnhanced Diabetes EducationEnhanced Diabetes Education
Primary Outcome Measures
NameTimeMethod
Improvement in A1C at 12 months12 months

The primary outcome will be the improvement in A1C at 12 months between Intervention group patients and Control group patients.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath